PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGenetic screening of embryos makes no difference to births

BioNews

Genetic screening of embryos makes no difference to births

Published 10 August 2018 posted in News and appears in BioNews 962

Author

Dr Charlott Repschläger

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet...

Preimplantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet.

Professor Karen Sermon at the Vrije Univeriteit in Brussels, Belgium, who led the study, said she 'saw no benefit' in using the controversial technique (see BioNews 930) which assesses chromosomal abnormalities to help select for embryos for implantation in IVF.

The randomised controlled trial followed 396 women aged 36 to 40 years undergoing treatment at fertility centres in seven countries from 2012. About half the patients received PGT-A (pre-implantation genetic testing for aneuploidy) prior to embryo implantation, while the other half received IVF only.

After one year and the first cycle of IVF, the percentage of women from both groups who had had a baby was identical at 24 percent.

The second endpoint of the study looked at the rate of miscarriages and embryo transfers and found that with PGT-A both were significantly reduced, with miscarriages decreasing from 14 percent in the IVF only group, to 7 percent in the PGT-A group.

The researchers note that the results indicate a possible greater efficiency of transfers with PGT-A, but caution that it has yet to be seen whether these benefits outweigh the cost and invasiveness of the procedure.

'All too often couples requiring IVF treatment are taken for a ride when it comes to a bewildering array of unproven tests and adjuvant treatments,' said Professor Jan Brosens at the University of Warwick in the UK, who was not involved in the study.

'Patients need to be empowered to make choices based on clinical evidence. This smartly designed and well conducted study was designed to give couples clear-cut information on whether PGT-A increases the chance of having a baby within one year. The answer is no.'

He added: 'Yet the finding that PGT-A reduces the number of procedures and decreases the risk of miscarriage may sway some couples to opt for this intervention.'

Some experts however caution that the decreased miscarriage rate seen might not be clear cut.

'The authors stated that as a result of PGT, there were less embryo transfers and a lower miscarriage rate, and many IVF clinics may well erroneously seize this as a "selling point" for PGT-A,' said Professor Ying Cheong at the University of Southampton, and clinical director of Complete Fertility in Southampton. 'It needs to be emphasised that these are secondary end-points which the study was not powered to definitively answer and so must be interpreted with caution.'

While the study has been praised by many experts for its design, many have also pointed to a major limitation: namely that the genetic screening method used is not one that is commonly used now.

The PGT-A in the study analysed the polar bodies – non-functional cells ejected by the egg prior to its first division after fertilisation (see BioNews 581). When the study started recruiting patients in 2012 this was a state-of-the-art technique. Using polar bodies to analyse the maternal chromosomes was seen as less invasive than taking cells from the actual embryo. However, the technique has since been replaced by the harvesting of genetic material from the blastocyst five days after fertilisation as methods of genetic analysis have improved.

The study was published in the journal Human Reproduction.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
26 November 2021 • 2 minutes read

PGT-A did not improve live birth rate in clinic trial

by Ruth Retassie

A recent study found that preimplantation genetic testing for aneuploidy may not improve live birth rate...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
5 November 2021 • 2 minutes read

Embryonic stem cells can self-destruct when defective

by Beatrice Costa

Insight into genetic control of human embryonic stem cells' fate has offered new insight into cancer genetics and could inform future work in regenerative medicine...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 May 2021 • 2 minutes read

Embryos often develop into healthy babies despite aneuploid genetic tests

by Dr Katie Howe

Some of the faulty embryos currently ruled out for use in IVF can self-correct and lead to healthy pregnancies, research has revealed..

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
15 January 2021 • 1 minute read

Lawsuit against Monash IVF over embryo testing method

by Anna Wernick

Hundreds of people across Australia are suing the major IVF clinic, Monash IVF, over the destruction of potentially viable embryos...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on Auguste Rodin's 'The Thinker').
CC BY 4.0
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on the sculpture 'The Thinker' by Auguste Rodin).
Reviews
18 September 2020 • 4 minutes read

Podcast Review: DNA Today — PGT for polygenic conditions

by Dr Valerie Shaikly

In this episode of 'DNA Today's' series about infertility, certified genetic counsellor Jennifer Eccles, head of genetic counselling at Genomic Prediction, put her case for a new type of preimplantation genetic testing, called PGT-P...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
2 July 2018 • 2 minutes read

Model predicts chance of having normal embryo as women age

by Shaoni Bhattacharya

Scientists say they have developed the most robust model yet to estimate how likely a woman is to have a chromosomally normal embryo for IVF depending on her age...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
4 January 2018 • 8 minutes read

Preimplantation genetic screening: unvalidated methods discard healthy embryos

by Norbert Gleicher

A seemingly brilliant hypothesis of preimplantation genetic screening arose in the 1990s when Dr Yuri Verlinsky proposed using polar body biopsies to detect chromosomal abnormalities in embryos prior to transfer in IVF...

Healthy embryos are discarded

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
7 September 2017 • 3 minutes read

Screen all chromosomes in prenatal embryo testing, says study

by Dr Rachel Huddart

Current prenatal chromosome screening tests could miss rare chromosomal abnormalities and lead to inaccurate results...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 May 2016 • 2 minutes read

IVF: the next generation — first UK baby born after DNA screening technique

by James Brooks

The UK's first baby resulting from an embryo that was screened using next-generation DNA sequencing has been born in Oxford...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« CRISPR editing human embryos - did it work or not?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856